| Literature DB >> 27748804 |
Young-Joo Jeon1, Woong Bang1, Jin Hyoung Cho1, Ra Ham Lee1, Seok-Ho Kim2, Minseok S Kim3, Seon-Min Park4, Jae-Cheon Shin4, Hak-Jae Chung5, Keon Bong Oh5, Jae-Min Seo6, Sungho Ko7, Jung-Hyun Shim8, Jung-Il Chae1.
Abstract
Kahweol, a diterpene molecule, has antiproliferative effects on several types of human cancer cells, but whether it has apoptotic effect in non-small cell lung cancer (NSCLC) is not known. To explore this possibility, we incubated cells from two NSCLC cell lines, NCI-H358 and NCI‑H1299, with different concentrations of kahweol and used the MTS assay, DAPI staining, propidium iodide staining, Annexin V staining, immunocytochemical test, and western blot analysis to characterize this molecule and the signaling pathway underlying its effects. The kahweol-treated cells showed significantly decreased cell viability, increased nuclear condensation, and an increased number of Annexin V-positive NSCLC cells. Suppression of basic transcription factor 3 (BTF3) was followed by apoptosis induced by kahweol via the ERK-mediated signaling pathway in a dose- and time-dependent manner. In addition, kahweol modulated the protein expression of BTF3 genes involved in cell-cycle regulation and apoptosis-related proteins, resulting in apoptotic cell death. Our results collectively indicated that kahweol inhibited the proliferation of NSCLC cells through ERK-mediated signaling pathways and the downregulation of BTF3.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27748804 DOI: 10.3892/ijo.2016.3727
Source DB: PubMed Journal: Int J Oncol ISSN: 1019-6439 Impact factor: 5.650